Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin Pharmacol Ther. 2001; 69: 89-95
- Requiem for a heavyweight: the demise of creatine kinase-MB.Circulation. 2008; 118: 2200-2206
- Third universal definition of myocardial infarction.Circulation. 2012; 126: 2020-2035
- Third universal definition of myocardial infarction.J Am Coll Cardiol. 2012; 60: 1581-1598
- A sensitive cardiac troponin T assay in stable coronary artery disease.N Engl J Med. 2009; 361: 2538-2547
- Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.Circulation. 2011; 123: 1367-1376
- Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.Mol Cell Biochem. 1992; 116: 155-162
- Prognostic value of serum concentration of heart-type fatty acid- binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome.Clin Chem. 2005; 51: 1397-1404
- Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.Eur Heart J. 2008; 29: 2843-2850
- Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.J Thromb Thrombolysis. 2013; 36: 361-367
- Incremental value of copeptin for rapid rule out of acute myocardial infarction.J Am Coll Cardiol. 2009; 54: 60-68
- Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.Heart. 2012; 98: 558-565
BIC-8 results ESC 2013. Available at: http://www.escardio.org/about/press/press-releases/esc13-amsterdam/Pages/hotline-four-bic-8.aspx. Accessed September 17, 2013.
- Natriuretic peptides in the diagnosis and management of chronic heart failure.Heart Fail Clin. 2009; 5: 501-514
- Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.Circ Heart Fail. 2013; 6: 1029-1038
- Heart failure outcomes and benefits of NT- proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.J Card Fail. 2012; 18: 626-634
- Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.Circulation. 2012; 125: 233-240
- Identification of serum soluble ST2 receptor as a novel heart failure biomarker.Circulation. 2003; 107: 721-726
- The IL-33/ST2 pathway: therapeutic target and novel biomarker.Nat Rev Drug Discov. 2008; 7: 827-840
- Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.J Am Coll Cardiol. 2007; 50: 1054-1060
- Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals.Clin Chem. 2013; 59: 1091-1098
- Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.Biochem Biophys Res Commun. 1993; 192: 553-560
- Increased plasma adrenomedullin levels in chronic congestive heart failure.Am Heart J. 1996; 131: 994-998
- High-sensitivity c-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation. 2001; 103: 1813-1818
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008; 359: 2195-2207
- Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions.JACC Cardiovasc Interv. 2013; 6: 945-954
- Are there really biomarkers of vulnerable plaque?.Clin Chem. 2012; 58: 151-153
- Plasma myeloperoxidase levels in patients with chronic heart failure.Am J Cardiol. 2006; 98: 796-799
- Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.Clin Chem. 2011; 57: 1762-1770
- Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.N Engl J Med. 2010; 363: 552-563
- Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.Circ Heart Fail. 2012; 5: 462-466
- Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.Circulation. 2004; 110: 3121-3128
- The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).Am Heart J. 2012; 164: 878-883
- Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22.Clin Chem. 2011; 273: 267-273
- CKD and Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study: interactions with age, sex, and race.Am J Kidney Dis. 2013; 62: 691-702
- Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet inhibition and patient Outcomes (PLATO) study.Clin Chem. 2013; 59: 1369-1375
- β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.J Am Coll Cardiol. 2011; 57: 849-858
- Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.J Cardiol. 2010; 55: 99-107
- Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.Heart. 2010; 96: 1297-1302
- Urinary kidney injury molecule 1 and incidence of heart failure in elderly men.Eur J Heart Fail. 2013; 15: 441-446
- Kidney injury molecule-1 and N-acetyl-ss-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.Eur J Heart Fail. 2011; 13: 1104-1110
- Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).J Am Coll Cardiol. 2012; 60: 200-207
- Mutation of the mouse klotho gene leads to a syndrome resembling ageing.Nature. 1997; 390: 45-51
- Suppression of aging in mice by the hormone Klotho.Science. 2005; 309: 1829-1833
- Association of human aging with a functional variant of klotho.Proc Natl Acad Sci U S A. 2002; 99: 856-861
- KLOTHO allele status and the risk of early-onset occult coronary artery disease.Am J Hum Genet. 2003; 72: 1154-1161
- Plasma klotho and cardiovascular disease in adults.J Am Geriatr Soc. 2011; 59: 1596-1601
- Translating metabolomics to cardiovascular biomarkers.Prog Cardiovasc Dis. 2012; 55: 70-76
- Metabolomics and cardiovascular biomarker discovery.Clin Chem. 2011; 58: 139-147
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.Nature. 2011; 472: 57-63
- Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.N Engl J Med. 2013; 368: 1575-1584
- Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.Nat Med. 2013; 19: 576-585
- Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris.Arterioscler Thromb Vasc Biol. 2013; 33: 2041-2048
- Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study research articles.J Proteome Res. 2010; 9: 6647-6654
- Functional screening identifies miRNAs inducing cardiac regeneration.Nature. 2012; 492: 376-381
- MicroRNA-133 controls cardiac hypertrophy.Nat Med. 2007; 13: 613-618
- MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.J Clin Invest. 2009; 119: 2772-2786
- MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.Cardiology. 2010; 115: 163-169
Article info
Publication history
Published online: January 16, 2014
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
